Alex Telford is the co-founder and CEO of Convoke Bio, a seed-stage biotech software startup leveraging AI to revolutionize drug development. With a background in life sciences consulting and deep experience across biotech and pharma, he is passionate about applying generative AI and machine learning to automate complex workflows, reduce information fragmentation, and enhance decision-making in areas like trial design, toxicity prediction, and regulatory strategy. A thoughtful thinker and writer, Telford focuses on asking the right questions—whether about digital twins, knowledge automation, or clinical innovation—to help reimagine how therapies are discovered, developed, and delivered.